Psychopharmacologic treatment of borderline personality disorder
Dialogues Clin Neurosci. 2013 Jun; 15(2): 213–224. PMCID: PMC3811092 PMID: 24174895 Luis H. Ripoll, MD* Author information Copyright and License information Disclaimer This article has been cited by other articles in PMC. Abstract The best available evidence for psychopharmacologic treatment of borderline personality disorder (BPD) is outlined here. BPD is defined by disturbances in identity and interpersonal functioning, and patients report potential medication treatment targets such as impulsivity, aggression, transient psychotic and dissociative symptoms, and refractory affective instability Few randomized…